These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18578091)

  • 1. Antiretroviral resistance in the developing world.
    Pillay D
    J HIV Ther; 2007 Dec; 12(4):95-6. PubMed ID: 18578091
    [No Abstract]   [Full Text] [Related]  

  • 2. The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world.
    Bennett DE
    Curr Opin Infect Dis; 2006 Dec; 19(6):607-14. PubMed ID: 17075338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of antiretroviral resistance and impact on treatment outcomes.
    Cane P
    J HIV Ther; 2007 Dec; 12(4):82-4. PubMed ID: 18391892
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV resistance and the developing world.
    Gupta RK; Pillay D
    Int J Antimicrob Agents; 2007 May; 29(5):510-7. PubMed ID: 17346940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow accumulation of HIV resistance mutations: implications for resource-limited settings?
    Stevens WS
    J Infect Dis; 2009 Sep; 200(5):670-2. PubMed ID: 19604045
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection.
    Krogstad PA
    J Infect Dis; 2007 May; 195(10):1393-5. PubMed ID: 17436216
    [No Abstract]   [Full Text] [Related]  

  • 7. The K65R mutation: selection, frequency, and possible consequences.
    Moyle GJ
    AIDS Read; 2004 Nov; 14(11):595-7, 601-3. PubMed ID: 15570671
    [No Abstract]   [Full Text] [Related]  

  • 8. Accrued HIV evidence turns treatment dogma on its head.
    Check E
    Nature; 2003 Aug; 424(6951):866. PubMed ID: 12931150
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigm.
    Moatti JP; N'Doye I; Hammer SM; Hale P; Kazatchkine M
    Nat Med; 2003 Dec; 9(12):1449-52. PubMed ID: 14647513
    [No Abstract]   [Full Text] [Related]  

  • 10. Choice of an initial antiretroviral regimen in the resource-limited setting: the cost of virologic failure.
    Campbell TB
    Clin Infect Dis; 2008 Sep; 47(5):723-5. PubMed ID: 18662135
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-resistant HIV.
    Laurence J
    AIDS Read; 2001 Aug; 11(8):384-5. PubMed ID: 11570260
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiretroviral rounds. Resistance: how do you know if you don't know?
    Campbell TB; Katzenstein D
    AIDS Clin Care; 2005 Mar; 17(3):26-7. PubMed ID: 15828117
    [No Abstract]   [Full Text] [Related]  

  • 13. [German-Austrian guidelines for antiretroviral therapy of HIV infection. (July, 2002, update)].
    Brockmeyer NH; ;
    Dtsch Med Wochenschr; 2003 May; 128 Suppl 1():S7-18. PubMed ID: 12736863
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiretroviral drug resistance and HIV/AIDS in the developing world.
    Vella S
    J HIV Ther; 2002 Aug; 7(3):53-5. PubMed ID: 12442164
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV drug resistance and you. Resistance overview. A look at the basics.
    Munk B
    Posit Aware; 2006; Spec No():6-9. PubMed ID: 16583502
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV/AIDS. Tangled patent dispute over 'free' drug-resistance database.
    Cohen J
    Science; 2009 Feb; 323(5918):1156-7. PubMed ID: 19251598
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful application of laboratory tools for the detection of HIV drug resistance in routine clinical care in Georgia.
    Chkhartishvili N; Dvali N; Gochitashvili N; Sharvadze L; Tsertsvadze T
    Georgian Med News; 2008 Dec; (165):16-22. PubMed ID: 19124911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.
    Elliott JH; Lynen L; Calmy A; De Luca A; Shafer RW; Zolfo M; Clotet B; Huffam S; Boucher CA; Cooper DA; Schapiro JM
    AIDS; 2008 Oct; 22(16):2053-67. PubMed ID: 18753937
    [No Abstract]   [Full Text] [Related]  

  • 19. Guideline watch. Antiretroviral drug resistance testing--updated guidelines from the IAS-USA.
    Hicks CB
    AIDS Clin Care; 2008 Aug; 20(8):64. PubMed ID: 18814369
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical data marshalled to treat HIV.
    Clarke T
    Nature; 2003 Jun; 423(6942):791. PubMed ID: 12815390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.